SHE:300347 - Hangzhou Tigermed Consulting Co Ltd

Hangzhou Tigermed Consulting
Sector: Health Care, Industry: Life Sciences Tools & Services

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2009 Q4	2010 Q4	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.8B 10.2%	4.29B 12.9%	5.21B 21.6%	6.13B 17.6%	6.75B 10.1%	7.22B 7.0%	7.09B -1.9%	7.07B -0.2%	7.2B 1.8%	7.33B 1.8%	7.38B 0.7%	7.24B -2.0%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.01B 11.1%	2.3B 14.6%	2.94B 27.9%	3.58B 21.5%	4.03B 12.7%	4.37B 8.5%	4.28B -2.2%	4.25B -0.5%	4.34B 2.0%	4.41B 1.6%	4.54B 2.8%	4.48B -1.3%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.79B 9.3%	1.99B 11.1%	2.27B 14.3%	2.55B 12.4%	2.72B 6.5%	2.85B 4.9%	2.81B -1.5%	2.82B 0.3%	2.86B 1.6%	2.92B 2.0%	2.85B -2.4%	2.76B -3.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.76B 10.6%	3.13B 13.5%	3.84B 22.6%	4.53B 18.0%	5.01B 10.8%	5.36B 6.8%	5.27B -1.5%	5.28B 0.2%	5.41B 2.3%	5.54B 2.4%	5.63B 1.6%	5.57B -1.1%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	749.93M 9.2%	828.98M 10.5%	892.77M 7.7%	949.5M 6.4%	982.54M 3.5%	982.64M 0.0%	997.69M 1.5%	1.03B 3.1%	1.07B 3.7%	1.13B 5.7%	1.09B -3.1%	1.09B -0.2%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.04B 9.4%	1.16B 11.4%	1.38B 19.0%	1.6B 16.4%	1.74B 8.3%	1.87B 7.6%	1.81B -3.1%	1.79B -1.2%	1.8B 0.4%	1.79B -0.2%	1.76B -2.0%	1.67B -4.8%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.58B -	-	3.39B -	-	3.12B -	-	2.27B -	-	2.36B -	-	2.15B -	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.01B 2.9%	2.21B 10.3%	2.87B 29.9%	2.94B 2.2%	2.81B -4.3%	2.7B -4.0%	2.01B -25.6%	2.06B 2.5%	2.2B 7.1%	2.28B 3.6%	2.02B -11.2%	1.69B -16.5%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.3 -3.4%	2.54 10.4%	3.31 30.3%	3.39 2.4%	3.25 -4.1%	3.12 -4.0%	2.32 -25.6%	2.38 2.6%	2.55 7.1%	2.63 3.1%	2.34 -11.0%	1.95 -16.7%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.3 -3.0%	2.53 10%	3.3 30.4%	3.38 2.4%	3.24 -4.1%	3.12 -3.7%	2.32 -25.6%	2.38 2.6%	2.55 7.1%	2.63 3.1%	2.34 -11.0%	1.95 -16.7%